Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Andrology
Research from Cairo University, Biochemistry Department in andrology provides new insights
June 26th, 2007
Current study results from the report, "Assessment of heme oxygenase-1 (HO-1) activity in the cavernous tissues of sildenafil citrate-treated rats," have been published. Researchers in Cairo, Egypt conducted a study "To assess heme oxygenase-1 (HO-1) activity in the cavernous tissue of sildenafil citrate-treated rats. One hundred and ninety-two Sprague-Dawley male rats, divided into four equal groups, were investigated." "Group 1, the control group, received regular animal chow; group 2 received sildenafil citrate by intragastric tube; group 3 received sildenafil and HO inhibitor (zinc protoporphyrin, ZnPP); and group 4 received sildenafil and nitric oxide synthase...
Source: Drug Law Weekly (2007-06-26)
|
